BRCA1 and breast cancer: Five of six BRCA1/2 SNV/indel pathogenic mutation carriers were diagnosed with triple‐negative subtype, only one patient was diagnosed with luminal‐B subtype, and five of six patients were diagnosed with BC at ≤45 years.